Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Topical intravaginal microbicide development grant from NIAID open for applications.

This article was originally published in The Tan Sheet

Executive Summary

TOPICAL INTRAVAGINAL MICROBICIDE DEVELOPMENT GRANT FROM NIAID is open for researcher applications, according to a request for applications from the National Institute of Allergy & Infectious Diseases Sexually Transmitted Diseases Branch. The objective of the research program "is to develop products that are safe and effective in preventing and controlling sexually transmitted infection. Of interest are all products that prevent infection whether or not they also have the capacity to prevent pregnancy," the RFA states. The goal of the program is to develop topical microbicides "with activity against a combination of pathogens, including viral, bacterial and protozoan," the RFA notes.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088451

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel